Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study
THURSDAY, June 13, 2024 (HealthDay News) — CAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that the immunotherapy will create secondary cancers, a new study finds. The U.S. Food and Drug Administration issued a warning in November 2023 about a risk of secondaryContinue Reading










